Precigen
PGEN
127 hedge funds and large institutions have $71.7M invested in Precigen in 2024 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 17 closing their positions.
484% more call options, than puts
Call options by funds: $403K | Put options by funds: $69K
19% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 32
2.13% more ownership
Funds ownership: 24.06% → 26.19% (+2.1%)
2% less funds holding
Funds holding: 130 → 127 (-3)
12% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 17
25% less capital invested
Capital invested by funds: $95.9M → $71.7M (-$24.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$13.7M |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$2.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.98M |
| 4 |
Corient Private Wealth
Miami,
Florida
|
+$776K |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$631K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
-$645K |
| 2 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
-$299K |
| 3 |
SMH
Sanders Morris Harris
Houston,
Texas
|
-$248K |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$246K |
| 5 |
JP Morgan Chase
New York
|
-$245K |
PGEN Hedge Fund Activity: Q3 2024 in Review
127 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q3 2024, worth a combined $71.7M — down 25% from $95.9M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PGEN and 15 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 38 added.
The largest buyer was Adage Capital Partners, opening a new position worth an estimated $13.7M. The largest seller was D.E. Shaw & Co, cutting an estimated $645K.
- 127 institutional investors held Precigen (PGEN) as of Q3 2024, down from 130 in Q2 2024.
- Funds reported $71.7M of Precigen stock for Q3 2024, down 25% quarter-over-quarter.
- 15 funds opened new Precigen positions in Q3 2024 and 17 closed out, a net change of -2 holders.
- The largest Precigen buyer in Q3 2024 was Adage Capital Partners, an estimated $13.7M added.
- The largest Precigen seller in Q3 2024 was D.E. Shaw & Co, an estimated $645K sold.
Based on aggregated 13F filings for Q3 2024.